---
schema_version: '1.0'
id: government-20260728-8922ae
content_kind: government-document
url: https://eur-lex.europa.eu/legal-content/AUTO/?uri=OJ:L_202601819
url_hash: 8922ae1a72ee805ee581594e3cb1c47e43677960990a011d1b8f0f2cdbfc7504
canonical_url: https://eur-lex.europa.eu/legal-content/AUTO?uri=OJ%3AL_202601819
source: eu-eurlex
category: government/eu
category_raw: official-journal-l
country: eu
region: eu
tags: []
lang: en
published_at: '2026-07-28T22:00:00Z'
fetched_at: '2026-07-29T03:00:59.653708Z'
updated_at: '2026-07-29T03:22:22Z'
status: published
content_hash: 235a20787d377eb634c6cf9f7674bd1bf5a33df8cd02019b81477593be0040e1
content_changed_at: null
license_note: full
license_basis: cc-by-4.0-decision-2011-833-eu
body_available: false
attribution: 'Source: © European Union, EUR-Lex (https://eur-lex.europa.eu/legal-content/AUTO?uri=OJ%3AL_202601819),
  CC BY 4.0 (Commission Decision 2011/833/EU). Summarized/translated by portal4Agents;
  changes were made.'
license_rule: source:eu-eurlex
summary: 欧州委員会は、遺伝子組み換え生物を含む製品の市販に関する許可保持者とその代表者について、複数の規制を改正する決定を2026年7月27日に採択した。改正内容にはBASFおよびM.S.
  Technologiesなどの企業が関与する新たな代表機関の指定が含まれる。
summary_source: llm
summary_en: 欧州委員会は、遺伝子組み換え生物を含む製品の市販に関する許可保持者とその代表者について、複数の規制を改正する決定を2026年7月27日に採択した。改正内容にはBASFおよびM.S.
  Technologiesなどの企業が関与する新たな代表機関の指定が含まれる。
provenance:
  doc_id: tag:google.com,2005:reader/item/000657b6c6d931e1
  doc_id_scheme: rss_guid
  issuer:
  - Publications Office of the European Union
  doc_type: official-journal-l
  feed_title: 5 - Acts of the Official Journal L
entities:
- name: European Commission
  type: organization
- name: decision making last millisecond
  type: event
- name: July
  type: UNKNOWN
- name: financial instruments
  type: concept
key_facts: []
related: []
related_auto:
- name: China Department of Technology
  type: organization
  weight: 1.0
- name: United States
  type: location
  weight: 1.0
- name: Spain
  type: location
  weight: 1.0
- name: Google Workspace
  type: content
  weight: 1.0
title: 'OJ:L_202601819: Commission Implementing Decision (EU) 2026/1819 of 27 July
  2026 amending a number of instruments as regards the authorisation holders and their
  representatives in the Union for the placing on the market of products containing,
  consisting of or produced from certain genetically modified organisms (notified
  under document C(2026) 5096)'
---

# OJ:L_202601819: Commission Implementing Decision (EU) 2026/1819 of 27 July 2026 amending a number of instruments as regards the authorisation holders and their representatives in the Union for the placing on the market of products containing, consisting of or produced from certain genetically modified organisms (notified under document C(2026) 5096)

## TL;DR
欧州委員会は、遺伝子組み換え生物を含む製品の市販に関する許可保持者とその代表者について、複数の規制を改正する決定を2026年7月27日に採択した。改正内容にはBASFおよびM.S. Technologiesなどの企業が関与する新たな代表機関の指定が含まれる。

## Key Points
- (なし)

## Details
(本文なし。リンク先参照)

## Source
元記事: [OJ:L_202601819: Commission Implementing Decision (EU) 2026/1819 of 27 July 2026 amending a number of instruments as regards the authorisation holders and their representatives in the Union for the placing on the market of products containing, consisting of or produced from certain genetically modified organisms (notified under document C(2026) 5096)](https://eur-lex.europa.eu/legal-content/AUTO/?uri=OJ:L_202601819) — published 2026-07-28T22:00:00Z